Autoradiolysis of the 2-deoxy-2-[18F]fluoro-D-glucose radiopharmaceutical

被引:0
|
作者
E. Búriová
F. Macášek
F. Melichar
M. Kropáček
L. Procházka
机构
[1] Comenius University,
[2] Faculty of Natural Sciences,undefined
[3] Department of Nuclear Chemistry,undefined
[4] Slovak Office of Standards,undefined
[5] Metrology and Testing,undefined
[6] Cyclotron Center Section,undefined
[7] Czech Academy of Sciences,undefined
[8] Nuclear Physics Institute,undefined
[9] Department of Radiopharmaceuticals,undefined
[10] Czech Academy of Sciences,undefined
[11] Nuclear Physics Institute,undefined
[12] Department of Radiopharmaceuticals,undefined
[13] Czech Academy of Sciences,undefined
[14] Nuclear Physics Institute,undefined
[15] Department of Radiopharmaceuticals,undefined
来源
Journal of Radioanalytical and Nuclear Chemistry | 2005年 / 264卷
关键词
Arabinose; Glucuronic Acid; Radiochemical Yield; Residual Glucose; Modify Silica;
D O I
暂无
中图分类号
学科分类号
摘要
To control virtually the toxic compounds and to improve quality control of the solution of 2-deoxy-2-[18F]fluoro-d-glucose (2-[18F]FDG), the products of its autoradiolysis were analyzed by high-performance liquid chromatography with electrospray mass spectrometric and radiometric detectors (HPLC/MS/RAD), thin layer chromatography on TLC silica plate and HPTLC on amino modified silica plate. Except Kryptofix™ 2.2.2, glucose and fluoride anion, no by-products and impurities were observed by LC/MS analysis of fresh 2-[18F]FDG samples. The analysis performed in the time interval of 6 to 48 hours after the end of 2-[18F]FDG synthesis indicated that the activity of the autoradiolysis products separated by HPLC did not exceed 1.3%. As the main autoradiolysis products of 3.3 . 10-5 to 4.4 . 10-5M 2-[18F]FDG solution of original specific activity 0.5-1.5 GBq . cm-3 were established: arabinose - 2.8 μM (G= 0.07/100 eV), gluconic and glucuronic acids 1.8-0.5 μM (G =0.01-0.05/100 eV), arabinose and araburonic acids occurred under 0.5 μM concentration at residual glucose contents about 0.14 mM. Radiation chemical yields of active products were calculated from molar activity of 2-[18F]FDG and the percentage of their activity: 0.5% radiochemical yield of 2-[18F]fluoroglucuronic acid corresponds to the G = 0.004/100 eV and 0.3% yield of 2-[18F]fluorogluconic acid issues G = 0.003/100 eV.
引用
收藏
页码:595 / 602
页数:7
相关论文
共 50 条
  • [31] Fate of 2-deoxy-2-[18F]fluoro D-glucose in hyperglycemic rats
    Malaisse, WJ
    Damhaut, P
    Ladriere, L
    Goldman, S
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2000, 6 (05) : 549 - 552
  • [32] A NEW SYNTHESIS OF 2-DEOXY-2-[F-18]FLUORO-D-GLUCOSE WITH ANHYDROUS [F-18] FLUORIDE
    LEVY, S
    LIVNI, E
    ELMALEH, DR
    JOURNAL OF NUCLEAR MEDICINE, 1982, 23 (05) : P107 - P107
  • [33] 2-Deoxy-2-[F-18]fluoro-D-glucose accumulation in ovarian carcinoma cell lines
    Lutz, A. M.
    Ray, P.
    Willmann, J. K.
    Drescher, Charles
    Gambhir, S. S.
    MOLECULAR IMAGING AND BIOLOGY, 2007, 9 (05) : 260 - 266
  • [34] 2-DEOXY-2-[F-18] FLUORO-D-GLUCOSE ACCUMULATION IN METASTATIC LIVER-TUMOR
    YONEKURA, Y
    BENUA, RS
    BRILL, AB
    SOM, P
    YEH, S
    KEMENY, NE
    FOWLER, JS
    MACGREGOR, RR
    STAMM, R
    WOLF, AP
    JOURNAL OF NUCLEAR MEDICINE, 1982, 23 (05) : P8 - P8
  • [35] 2-Deoxy-2-[F-18]fluoro-d-glucose Accumulation in Ovarian Carcinoma Cell Lines
    A. M. Lutz
    P. Ray
    J. K. Willmann
    Charles Drescher
    S. S. Gambhir
    Molecular Imaging and Biology, 2007, 9 : 260 - 266
  • [36] Positron emission tomography agent 2-deoxy-2-[18F]fluoro-D-glucose has a therapeutic potential in breast cancer
    Renee M Moadel
    Andrew V Nguyen
    Elaine Y Lin
    Ping Lu
    Joseph Mani
    M Donald Blaufox
    Jeffrey W Pollard
    Ekaterina Dadachova
    Breast Cancer Research, 5
  • [37] Standardized Uptake Value Atlas: Characterization of Physiological 2-Deoxy-2-[18F]fluoro-d-glucose Uptake in Normal Tissues
    Yingbing Wang
    Edison Chiu
    Jarrett Rosenberg
    Sanjiv Sam Gambhir
    Molecular Imaging and Biology, 2007, 9 : 83 - 90
  • [38] 2-Deoxy-2-[18F] Fluoro-D-Glucose PET/Computed Tomography Therapy Response Assessment in Head and Neck Cancer
    Sheikhbahaei, Sara
    Subramaniam, Rathan M.
    Solnes, Lilja B.
    PET CLINICS, 2022, 17 (02) : 307 - 317
  • [39] Adjustment of vascular 2-deoxy-2-[18F]fluoro-d-glucose uptake values over time through a modeling approach
    Kafouris, Pavlos P.
    Koutagiar, Iosif P.
    Georgakopoulos, Alexandros T.
    Pianou, Nikoletta K.
    Metaxas, Marinos G.
    Spyrou, George M.
    Anagnostopoulos, Constantinos D.
    INTERNATIONAL JOURNAL OF CARDIOVASCULAR IMAGING, 2019, 35 (05): : 955 - 964
  • [40] Integration of 2-deoxy-2-[18F] fluoro-d-glucose PET/CT into clinical management of patients with Wegener’s granulomatosis
    Ozlem Ozmen
    Ebru Tatci
    Atila Gokcek
    Deniz Koksal
    Yeliz Dadali
    Esra Ozaydin
    Nuri Arslan
    Annals of Nuclear Medicine, 2013, 27 : 907 - 915